SNOA Wutah bathi saben saham ing taun iki Sonoma Pharmaceuticals

SNOA (sonomapharma.com) - tandha merek perusahaan

Sonoma Pharmaceuticals develops tissue regeneration products using affordable formulas for mass production. Manufacturing processes are fully outsourced to external contractors, leaving the company dependent on third-party plants. The current stage of development is characterized by the promotion of the Microcyn line through veterinary centers and pharmacies. The annual EPS percentage change demonstrates profitability dynamics, where the value 0.00 represents the current figure.

SNOA Wutah bathi saben saham ing taun lumaku sonomapharma.com (04.07.2022 - 18.11.2026)

Rincian analitis lan laporan data perusahaan sonomapharma.com (SNOA)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:SNOA, Sonoma Pharmaceuticals
Produk merek Sonoma Pharmaceuticals

Fundamental asset screening requires an accurate assessment of shareholder value dynamics. By analyzing the percentage deviation of EPS from the previous year's level, an investor determines the rate of change in net profit per share, which reveals the business's resilience to market shocks. For Sonoma Pharmaceuticals (SNOA), this indicator reflects the effectiveness of diversification within the dermatology and hygiene segment when supplying global pharmacy chains.